The Melbourne Consensus Statement on the early detection of prostate cancer. - Wikidata - awgldk - TriplyDB

The Melbourne Consensus Statement on the early detection of prostate cancer.

The Melbourne Consensus Statement on the early detection of prostate cancer.

http://www.wikidata.org/entity/Q38160903

about

The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements A comparison of genetic risk score with family history for estimating prostate cancer risk Is anyone listening? Variation in PSA screening among providers for men 75+ before and after United States Preventive Services Task Force recommendations against it: a retrospective cohort study.Digital rectal examination in primary care is important for early detection of prostate cancer: a retrospective cohort analysis study.Prostate-specific antigen-based screening: controversy and guidelines The Prostate Health Index: Its Utility in Prostate Cancer Detection Prostate cancer: measuring PSA.Prostate-specific antigen-based prostate cancer screening: Past and future.What's new in screening in 2015?Impact of branding on public awareness of healthcare-related governing bodies: a pilot study of the Urological Society of Australia and New Zealand brand.A Cost-Utility Analysis of Prostate Cancer Screening in Australia.European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study.An Ounce of Prevention: Deaths Averted From Primary Prevention Interventions.Improving multivariable prostate cancer risk assessment using the Prostate Health Index.Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer.Clinical Consultation Guide: How to Optimize the Use of Prostate-specific Antigen in the Current Era.PSA screening: And now…a message from our experts Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.Prostate-specific antigen testing for prostate cancer screening: A national survey of Canadian primary care physicians' opinions and practices.Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.PSA screening: Time to overcome our brand confusion.The emerging use of Twitter by urological journals.The Clinical Efficacy of Prostate Cancer Screening in Worldwide and Iran: Narrative Review.Can active surveillance really reduce the harms of overdiagnosing prostate cancer? A reflection of real life clinical practice in the PRIAS study.Time to replace prostate-specific antigen (PSA) with the Prostate Health Index (PHI)? Yet more evidence that the PHI consistently outperforms PSA across diverse populations.Prostate cancer: Growth of AS in the USA signals reduction in overtreatment.Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic.

P2860

Q26750672-EE4518CB-B5E9-4865-8037-3C4A6F7CCB59 Q26752649-9477597B-42D6-47B0-872F-AEDF2725D882 Q34160375-D24042C7-4E0B-41F9-BF85-AA80BBC20012 Q34555221-6C2A727A-EAF7-47CB-AEF2-FDB0E88098C3 Q35211931-EC40688E-BF6C-477E-8FAE-66C7012BF9C1 Q36328005-2228E793-FF06-4032-B898-9AC920BEB9AE Q38210857-413AD6BA-42EC-457A-840A-690578DEA1F7 Q38408501-2659A223-5770-4446-90D6-4190184A1A9D Q38871819-39CA109D-C305-4C21-9A60-C07ABB83A945 Q39238133-905FCC38-BE87-440B-BA03-D1BCFDF7B922 Q39273026-2FC5D7C1-95B7-4787-93A4-FF40BF08EE5C Q40034472-922166EC-A66E-49B3-A7A9-24ACEACA7D92 Q40265005-C16AA0DB-EAB1-4D20-8D2F-4856591CFA1B Q40270088-143D78A9-EACB-4012-9FED-552D8DF7B0DF Q40412845-D2DD9271-21C9-41CC-A3AD-2EB7F3E917A3 Q41201216-D93D8384-A8CE-40D3-9060-87C8C8398B2A Q42110492-8B427DDD-B375-4CF5-A4B1-BAF15E0F18A2 Q47436741-D059A42C-EEBF-4674-8A4C-56F0CD8DAFF1 Q47857777-063AF2A3-7B1E-4949-8DF5-D1AFCE8CA64C Q49340500-03CA55BA-146A-46BE-B646-1D8F29C6984F Q49573737-965C893A-17DA-4CCB-9A5D-ABFE5297E21C Q51458530-2513D0B9-95D2-42AD-9AE2-49951E3B34C8 Q51734241-6B9C48E9-F687-46F0-898F-70D75621288D Q52624211-196F1387-9908-494C-93B1-AADDA33C5220 Q53570258-92E32A99-C490-44E9-816A-EB874B719234 Q53669778-1B4D4AB7-58C8-4741-9F7F-771FA2685071 Q55139905-CDBF9DA7-239F-459E-BEBE-14A9A5741567

P2860

The Melbourne Consensus Statement on the early detection of prostate cancer.

http://www.wikidata.org/entity/Q38160903

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

The Melbourne Consensus Statement on the early detection of prostate cancer.

@en

type

label

The Melbourne Consensus Statement on the early detection of prostate cancer.

@en

prefLabel

The Melbourne Consensus Statement on the early detection of prostate cancer.

@en

P1433

Q38160903-7EAF438A-6F38-4525-8D16-891587D846BD

P1476

Q38160903-ADF5E9BA-55D3-44C1-8719-CCDF88A3D2B0

P2093

Q38160903-01EB9E54-3E33-4ED5-AC53-8AD65F746298

Q38160903-1491C386-1A38-4E52-B0B3-D828CBC8B1C6

Q38160903-2617524C-B75A-4F58-8313-032CC08854E2

Q38160903-30B8BA36-1A07-4546-8A1E-0033945759A3

Q38160903-8CE5230D-C60B-4768-BE64-AF1485985B93

Q38160903-93A77052-592C-4CD8-A4BD-58EDCBF4F0EF

Q38160903-9D920949-9F7B-4D29-B5F9-29EB1E7A11B3

Q38160903-A236C2D7-EB92-4ED1-B1F0-4C0D7E46201C

Q38160903-A510825B-6380-43A3-A100-40EF7BEE8393

Q38160903-BB11FF39-BE95-447F-854A-A063848CAD13

P2860

Q38160903-05766335-A38E-478A-B222-3D17A9C03758

Q38160903-08DB6339-9D6D-4257-9928-EC89EBF935BF

Q38160903-22265470-0024-4E9A-AAFB-21314853D834

Q38160903-2BF5AEA9-C95F-4329-B3DB-C162CFF51AB4

Q38160903-69BA9A31-A416-454C-B6BE-25F6F76FDCBA

Q38160903-6F2DE54A-2DE5-4603-B2BA-529435E11E0D

Q38160903-75F599E0-897F-4306-98EC-E1A7FD48B3EC

Q38160903-BDEA649F-9357-41FD-BE9D-36E3F21A38A9

Q38160903-C57B7F78-7E42-4735-A2D4-131B21318187

Q38160903-DB14F3A9-3A24-448D-B894-2C1E7CC7149A

P304

Q38160903-514D0E8A-A1A9-4C7D-AB28-C5EA56877FC2

P31

Q38160903-E28A2095-F18E-4169-8ED9-B8C226EDC622

P356

Q38160903-6A2F233B-ADB6-4861-A945-E7A0AC0FA686

P433

Q38160903-456DA13C-211D-4CC4-91BE-8834FCA85785

P478

Q38160903-A40DFA6E-F684-4A6E-B531-5A55A6DE12DA

P50

Q38160903-384A61BE-A016-49F0-A743-2169A125DDF5

Q38160903-3D69FC5C-310E-43E9-BFA1-2CBBB846BC70

Q38160903-4EC1B4E9-7129-4BBF-B290-1B586D793563

Q38160903-571F0118-E580-4E12-94CB-2D68FA12B3D0

Q38160903-7F50C2B5-C4DB-47D9-B1DB-FB9C5DD809B8

P577

Q38160903-BF76DBA9-C6A9-42F3-8231-012B8F4E5012

P5875

Q38160903-34223CA5-B708-4AA7-8741-CEA839F73B34

P698

Q38160903-785809EC-CBA6-4131-A688-422588B66068

P356

P1433

BJU International

P1476

The Melbourne Consensus Statement on the early detection of prostate cancer.

@en

P2093

Addie Wootten

http://www.w3.org/2001/XMLSchema#string

Anthony J Costello

http://www.w3.org/2001/XMLSchema#string

David Gillatt

http://www.w3.org/2001/XMLSchema#string

Declan G Murphy

http://www.w3.org/2001/XMLSchema#string

Helen Crowe

http://www.w3.org/2001/XMLSchema#string

Jane Crowe

http://www.w3.org/2001/XMLSchema#string

Martin Gleave

http://www.w3.org/2001/XMLSchema#string

Oliver Sartor

http://www.w3.org/2001/XMLSchema#string

Patrick C Walsh

http://www.w3.org/2001/XMLSchema#string

Tom Pickles

http://www.w3.org/2001/XMLSchema#string

P2860

Early detection of prostate cancer: AUA Guideline.

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

Prostate-cancer mortality at 11 years of follow-up.

Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50.

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

The Prostate cancer Research International: Active Surveillance study.

Early detection of prostate cancer: European Association of Urology recommendation.

Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time.

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer.

P304

186-188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJU.12556

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Thomas E Ahlering

Matthew R Cooperberg

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258425063

http://www.w3.org/2001/XMLSchema#string

P698

24206066

http://www.w3.org/2001/XMLSchema#string